From Boston Scientific Corp Conference Call; Co. Says Mesh Market Withdrawal Represents A 30 Basis Point Drag To Q1 And FY19 Organic Growth; Says Peripheral Interventions Business Felt Impact Of Paclitaxel-Related Concerns In Second Half Of Q1